It has recently been shown that 17 O magnetic resonance (MR) spectroscopic imaging at ultrahigh fields provides a reliable method for measuring CMRO 2 during a short period of 17 O 2 gas inhalation. The mathematical (or complete) model used in the 17 O MR method for calculating CMRO 2 requires simultaneous measurements of multiple parameters including the concentration of H 2 17 O produced in the brain tissue from inhaled 17 O 2 gas (C b ), CBF, and the input function for the H 2 17 O concentration in the feeding artery (C a ). Both invasive and noninvasive measurements are involved in determining all of these parameters. In this article, two simplified methods are proposed and validated for calculating CMRO 2 based on 17 O MR measurement(s); the first method requires the measurements of C b and CBF, but not C a , and the second method only requires a single noninvasive measurement of C b . The simplified methods were used to calculate CMRO 2 in anesthetized rat brain, and the results were compared with those obtained using the complete model. The results from this work show (1) the validity of the simplified methods for quantifying CMRO 2 , and (2) the feasibility for establishing a completely noninvasive 17 O MR approach for imaging CMRO 2 in vivo. Key Words: 17 O NMR-17 O MR spectroscopic imaging-Cerebral blood flow-Cerebral metabolic rate of oxygen-CMRO 2 .
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Oxidative metabolism of brain under both normal and pathologic conditions can be evaluated through the measurement of the cerebral metabolic rate of oxygen consumption (CMRO 2 ) (Siesjo 1978) . This can be accomplished by 15 O positron emission tomography (PET), which monitors the concentration change of the metabolic H 2 15 O generated by mitochondrial respiration in the brain during an inhalation of 15 O 2 gas (e.g., (Mintun et al., 1984) ). However, this is a complex measurement. It requires independent determinations of cerebral H 2 15 O content, CBF, and H 2 15 O present in the arterial supply to the brain (the arterial input function) (Mintun et al., 1984) ; in addition, it is necessary to experimentally determine (Mintun et al., 1984) or make assumptions (Ohta et al., 1992) about cerebral blood volume (CBV). The CBV complication arises because the PET method is unable to distinguish the radioactive signals coming from the 15 O 2 bound to hemoglobin or freely dissolved in blood from those emitted by the 15 O atoms in the metabolically generated H 2 15 O molecules. An alternative approach for measuring CMRO 2 is the use of 17 O MR spectroscopy (MRS) or MR spectroscopic imaging (MRSI) techniques to monitor concentration changes of metabolic H 2 17 O during an inhalation of the oxygen gas enriched with the nonradioactive 17 O isotope (i.e., 17 O 2 ) (Arai et al., 1990 (Arai et al., , 1991 Fiat and Kang, 1992; Mateescu et al., 1989; Pekar et al., 1991 Pekar et al., , 1995 Zhu et al., 2002) . This is analogous to the PET approach. However, the 17 O MR method has two major advantages compared with the PET technique. First, the 17 O 2 molecules, either in the form of free gas or bound to the hemoglobin in the blood, are nuclear magnetic resonance (NMR) invisible; consequently, 17 O MR detects the metabolically generated H 2 17 O specifically without the effects of confounding signals from other 17 O species (thereby avoiding the CBV complication). Second, the absolute concentration of metabolically generated H 2 17 O, and in turn CMRO 2 , can be precisely calculated by using the natural abundance H 2 17 O signal as an endogenous concentration reference; in the absence of enrichment, the 0.037% of water molecules naturally contain 17 O atoms. Therefore, the natural abundance H 2 17 O content per gram tissue or concentration is known in both brain tissue and blood.
The major disadvantage of the NMR method is the low inherent sensitivity of 17 O MR detection due to the small gyromagnetic ratio of the 17 O nucleus. We have, however, recently shown that the sensitivity of 17 O MR detection is improved significantly at ultrahigh magnetic fields, and an approximately fourfold signal-to-noise ratio gain can be obtained at 9.4 T compared with 4.7 T (Zhu et al., 2001) . In view of the sensitivity gains available with the use of ultrahigh-field magnets, and the potential advantages compared with the PET technique, 17 O MR approach may provide a viable and more accurate method for measuring CMRO 2 . The central remaining problem, however, is the determination of all the necessary parameters for modeling and calculating CMRO 2 .
Even though the 17 O MR approach does not have the CBV complication that afflicts the PET technique, it still, in principle, requires three independent determinations of cerebral H 2 17 O concentration [C b (t)], arterial input function for H 2 17 O [C a (t)], and CBF, as in PET. This can be ascertained from a model originally established by Kety and Schmidt (1948a,b ) (referred to as the "complete model" in this article) and schematically illustrated in Fig. 1 . We have recently shown that when all these three parameters were rigorously determined, then the 17 O MR approach indeed yielded an accurate measurement of CMRO 2 (Kety and Schmidt 1948a,b; Zhu et al., 2002) . However, the measurements of two of these parameters required for the complete model, namely the arterial H 2 17 O input function and CBF, pose technical difficulties (as they do in the PET method), and ultimately limit the utility of the approach.
The determination of the arterial H 2 17 O input function, practically requires an invasive procedure such as withdrawing arterial blood (preferably from the carotid arteries) at regular time intervals from the subject and determining arterial H 2 17 O concentration, as in PET studies, or using an implanted 17 O radiofrequency (RF) coil around the carotid artery, and continuously measuring arterial H 2 17 O concentration with 17 O NMR (Zhang et al., 2003; Zhu et al., 2002) . Both of these approaches are highly invasive; the former can induce physiologic perturbations, especially in small-animal studies (e.g., blood volume and the blood pressure changes), potentially affecting the basal CMRO 2 value. The latter, although it is accurate and avoids the deleterious physiologic consequences of blood depletion, does require a complex surgical procedure and is extremely difficult to perform in humans or in nonterminal animal experiments.
Measurement of CBF can be performed directly by using a number of MRI approaches (Detre et al., 1994; Kim 1995; Kwong et al., 1995; Silva et al., 1995) . However, the relatively low detection sensitivity of these approaches, especially in the brain areas with lower CBF values (e.g., the white matter), and the difficulty obtaining absolute CBF values using these approaches may lead to significant errors in CMRO 2 calculation.
It is, therefore, important to examine the feasibility of determining CMRO 2 reliably without having to measure C a (t) and, if possible, CBF. Using different approximations, attempts have already been made to simplify the measuring procedures and modeling for the calculation of CMRO 2 with the 17 O MR method. However, the va- of a general model describing the transportation and metabolism processes of oxygen molecules in the brain. After gas exchange in the lung, the inhaled O 2 molecules quickly bind to hemoglobin (Hb) in the blood, forming O 2 -Hb complexes (HbO 2 ). Through the feeding arteries/arterioles, the HbO 2 complex molecules are sent to the cerebral capillaries, where the O 2 molecules dissociate from the complex molecules, transport in the form of free gas across the blood-brain barrier (BBB), diffuse into the brain tissue (or cellular) space, and finally enter mitochondria where they are converted to metabolic water via oxidative metabolism. The metabolic water molecules can cross the mitochondrial membranes, move out of the brain cells, enter the draining venules/veins, and are washed out by the blood circulation. C a,HbO2 and C v,HbO2 are the HbO 2 concentration in the arterioles and venules, respectively, C a,H2O and C v,H2O are the metabolized H 2 O concentration in the arterioles and venules, respectively. (B) Schematic illustration of a simplified "complete model" describing the events in the brain when the lidity of the approximations proposed in these simplified models has not been rigorously tested by experiments and is still intensely debated Kang 1992, 1993; Pekar et al., 1991 Pekar et al., , 1995 . In this article, two simplified methods are proposed for CMRO 2 calculation with the 17 O MRS imaging approach (Zhu et al., 2002) . The first method allows calculation of CMRO 2 without the need to experimentally measure C a (t). The second method is an even simpler approach that requires the noninvasive measurement of C b (t) only, without having to determine C a (t) or CBF. The proposed models were experimentally evaluated by explicitly determining all parameters involved in the same animal so that CMRO 2 can be calculated from the same datasets using either the complete model or the simplified models. Figure 1A schematically illustrates the transportation and metabolism processes of oxygen molecules in the brain. After gas exchange in the lung, the inhaled O 2 molecules quickly bind to hemoglobin (Hb) in the blood, forming O 2 -hemoglobin complexes (HbO 2 ). Through the feeding arteries and arterioles, the HbO 2 complex permeates cerebral capillaries, where the O 2 molecules dissociate, cross the blood-brain barrier in the form of free gas, diffuse into the brain tissue (intracellular and extracellular) space, and finally enter mitochondria where they are converted to metabolic water via oxidative metabolism. The metabolic water molecules move out of the mitochondria, traversing the same pathway as O 2 entry but in reverse, and are washed out through venules and veins.
THEORY

General considerations
The key factor for the success of the 17 O MR approach is the detection sensitivity as well as the visibility of 17 O NMR. The critical parameters for determining the NMR sensitivity at different field strength are the longitudinal (T 1 ) and the transverse (T 2 ) relaxation times, and the magnetic field strength. The relaxation times of the 17 O spin, the only magnetic stable isotope of oxygen, are dominated by quadrapolar interactions (Abragam, 1961) . In the case of bulk water (excluding "bound" water in cells), for which the extreme narrowing limit is applicable (i.e., c << 1, where c is the rotational correlation time and is Larmor frequency in radians/s), the values of T 1 and T 2 due to quadrapolar interactions become
where the term of (e 2 Qq/h) is the quadrapolar coupling constant, and is an asymmetry parameter (0Յ Յ1) (Abragam 1961) . This mechanism results in rapid relaxation and very short T 1 and T 2 values (a few milliseconds), as well as broadening of the 17 O water resonance line width to approximately 100 to 200 Hz (Zhu et al., 2001) . There does exist a contribution from the 17 O-1 H scalar coupling on the 17 O T 2 relaxation in water, which is sensitive to the proton chemical exchange (Meiboom 1961) ; however, this effect is relatively small in in vivo tissues. In contrast to 17 O water, 17 O 2 , either as free gas or in a dissolved form in water, is strongly paramagnetic because of its two unpaired electrons, and hence undetectable because of the strong dipolar coupling between the electrons and the nucleus. When bound to hemoglobin, the 17 O 2 resonance is broadened beyond NMR detection owing to the extremely slow rotational motion of the oxyhemoglobin complex with large molecular weight. Saturation transfer electron paramagnetic resonance studies have shown that the c value for rotational motion of the hemoglobin molecule is 8 × 10 −6 seconds when the hemoglobin molecule is encapsulated within the erythrocyte membrane (Cassoly, 1982) . This is approximately 10 6 times slower than the rotational correlation time of bulk water (10 −12 − 10 −11 s) (Steinhoff et al., 1993) . Such slow rotational motion leads to extremely fast T 2 relaxation and renders the 17 O 2 molecule bound to hemoglobin invisible in 17 O MR data. Therefore, 17 O MR signal becomes detectable only when 17 O 2 is incorporated into water. This unique specificity makes it possible that 17 O NMR detects the metabolically generated H 2 17 O without confounding signals from the 17 O 2 molecules bound to hemoglobin or dissolved in tissue space. The general model described in Fig. 1A , therefore, can be significantly modified to a simple model via the elimination of the 17 O 2 components. Figure 1B illustrates the modified "complete model" for 17 O MR studies, where only the MR detectable 17 O-labeled H 2 17 O molecules in the three compartments (artery, venule, and the brain tissue including capillaries) are involved.
In the modified "complete model" for 17 O MR measurements ( Fig. 1B) , the vascular compartment of arteriole is replaced by artery because of the approximately identical H 2 17 O contents in arteriole and artery. Another approximation applied in this model is to include the vascular compartment of capillary into the brain tissue. In fact, the contribution of the H 2 17 O contents inside the capillaries is negligible because of the small capillary blood volume in the brain (approximately 2%). Henceforth, we will refer to the model in Fig 1B as the "complete model" accounting for all relevant parameters in this modified model.
Complete CMRO 2 model for the 17 O magnetic resonance approach
As illustrated by Fig. 1B , the mass balance relation of the concentration of labeled H 2 17 O in the brain tissue during the period of inhalation of 17 O 2 gas is given by:
where C a , C b and C v are the H 2 17 O concentration expressed in excess of the natural abundance H 2 17 O concentration in the arterial blood, brain tissue, and venule blood, respectively, as a function of 17 O 2 inhalation time t (unit ‫ס‬ minute). One labeled 17 O 2 converts to two H 2 17 O molecules through oxidative metabolism; thus, a constant of 2 is used in Eq. 3. The parameter ␣ in Eq. 3 is the 17 O enrichment fraction in the inhaled 17 O 2 gas (no unit). Appropriate use of Eq. 3 requires the units to be consistent among all parameters contained in the equation. Natural abundance H 2 17 O concentration is equal to 20.35 mol per gram brain water for brain tissue and mol per gram blood water in blood; this is based on the natural abundance H 2 17 O enrichment (0.037%) and the molecular weight of H 2 17 O (19.0). This concentration can be used to calibrate the absolute concentrations of C b (t), C a (t), and C v (t). Therefore, for convenience, the unit for C b is chosen as mol/(g brain water) and the units for C a and C v are mol/(g blood water). The parameter f 1 is a conversion factor that converts the CMRO 2 value to a conventional unit of mol · (g brain tissue) −1 · min −1 according to:
where ␤ brain is defined as (g brain water)/(g brain tissue) and is equal to 0.79 (Pekar et al., 1995; Ter-Pogossian et al., 1970) . The conventional CBF unit is (mL blood) · (g brain tissue) −1 · min −1 . Based on one common assumption that water in the brain tissue is in rapid equilibrium with water in venous blood,
where ‫)09.0ס(‬ is the brain/blood partition coefficient with the unit of (mL blood)/(g brain tissue) (Herscovitch and Raichle 1985) . The constant f 2 ‫)770.1ס(‬ is another conversion factor used for the consistency of unit for the expression of C b (t)/ and C v (t) terms. It is based on f 2 = unit of C b ͑t͒ր unit of C v ͑t͒ = ͑g brain tissue͒ и ͑g blood water͒ ͑mL blood͒ и ͑g brain water͒
where blood ‫ס‬ (g blood)/(mL blood) ‫50.1ס‬ (Altman, 1961) , and ␤ blood ‫ס‬ (g blood water)/(g blood) ‫ס‬ 0.81 (Ter-Pogossian et al., 1970) .
Substituting the C v (t) term in Eq. 3 using the equality f 2 C v (t) ‫ס‬ C b (t)/, as well as introducing two correction factors (m and n) into Eq. 3 leads to:
The correction factor m is used to account for the fact that water is not completely freely diffusible across the blood-brain barrier, which effectively reduces the rates of H 2 17 O perfusion and washout across this barrier. The value of m depends on CBF and is 0.84 for the CBF range of our experimental circumstances (Herscovitch et al., 1987) . The other correction factor n accounts for the fact that the washout rate of the metabolic H 2 17 O after the cessation of 17 O 2 inhalation was significantly slower than the washout rate of the H 2 17 O that permeates brain tissue subsequent to a bolus injection of H 2 17 O through the internal carotid artery in the rat (Zhu et al., 2002) . The value of n is given by the ratio of the washout rate of the metabolic H 2 17 O after the cessation of 17 O 2 inhalation versus that of the cerebral H 2 17 O after a bolus injection of H 2 17 O. This difference may be due to the additional restrictions imposed on the diffusion of metabolic water across the mitochondrial membrane.
Solving the linear differential equation of Eq. 6 gives:
In principle, the CMRO 2 value can be precisely calculated using Eq. 7 and the experimental data on C b (t), CBF, n, and C a (t). The primary aim of the two methods as presented in the upcoming sections of this article is to simplify CMRO 2 calculation without requiring C a (t) measurement or CBF measurement. In the first method (method I), CBF measurement for each image voxel is required. The second method (method II) provides a further simplified approach for CMRO 2 calculation, which does not require CBF and C a (t) measurements.
Simplified model: method I
The source of labeled water in the arterial input [i.e., C a (t)] is the metabolically created water in all the aerobic tissues in the entire animal which exchanges with the capillary water and enters into the venous and subsequently the arterial part through the blood circulation. This is often referred to as "recirculation." Assuming that there are no nonlinear effects introduced by water transport from tissues to capillaries, the concentration of H 2 17 O in blood (venous or arterial) should increase linearly during a brief 17 O 2 inhalation period (e.g., 2 minutes in our experiments). This assumption is justified based on the approximation that the metabolic H 2 from all organs can reach equilibrium with the water in venous blood rapidly compared with the rate it is produced by the mitochondria. Therefore, the concentration of H 2 17 O in the arterial blood, C a (t), can be assumed to have a linear dependence on the inhalation time t, i.e.,
where A is a constant. This linear relationship was in fact shown in our previous experiments based on invasive methods that allowed the continuous in vivo measurement of C a (t) (Zhu et al., 2002) . It is also supported by other studies (Arai et al., 1991; Pekar et al., 1991) . Substituting Eq. 8 into Eq. 7 provides the following solution for Eq. 3:
or,
[10]
According to Eq. 10, besides C b (t) and other known constants, both constant A and CBF are required to calculate CMRO 2 . In our experiments, CBF was measured from the "wash-out" rate of the inert diffusible tracer H 2 17 O in the brain tissue after a rapid bolus injection of H 2 17 O via a close feeding artery (Zhu et al., 2001) . Because metabolic H 2 17 O molecules are not generated in the absence of 17 O-labeled oxygen gas inhalation (i.e., the contribution from the first term on the right side of Eq. 3 is negligible), and C b (t) >> C a (t) subsequent to the passage of the bolus of H 2 17 O injected via a close feeding carotid artery, then
[11]
Solving Eq. 11 gives:
where C b (t 0 ) is the H 2 17 O concentration in the brain tissue at a time point t 0 when the bolus has essentially cleared from the arterial side (i.e., C b (t) >> C a (t) for t > t 0 ) and C o is a constant. Fitting the H 2 17 O tracer washout curve by an exponential decay function according to Eq. 12 gives the CBF value.
During a steady state of oxidative metabolism, CMRO 2 values calculated by Eq. 10 at different time points of C b (t) measurement should be a constant shortly after the onset of 17 O gas inhalation when the 17 O content in brain reaches a value that exceed the K m of cytochrome oxidase. In the rat, measurements according to the complete modeling for the 17 O MR approach revealed that this period was less than 0.5 minutes. Thus taking a derivative of Eq. 10 for time points beyond this initial delay period, yields an equation where the only unknown is A. Alternatively, the experimental data can be fitted to Eq. 10 using different A values until a time independent CMRO 2 value is obtained, as illustrated in the results section. Method I circumvents the invasive measurement of arterial input function that is extremely undesirable. With this simplified method, a partial or complete noninvasive model for the measurement of CMRO 2 through 17 O MR technology can be established.
Simplified model: method II
Measurement of CBF is still required in method I. This requirement increases the complexity of the experiment, even though this measurement can be accomplished noninvasively by the arterial spin tagging MR approaches; furthermore, another parameter of constant n requiring one invasive measurement (i.e., H 2 17 O bolus injection) is also needed in method I. To further simplify CMRO 2 measurements and calculation, the second simplified method is proposed. In this method, neither the CBF value nor the parameter of constant n has to be determined; furthermore, the assumption of a linear arterial input function versus the inhalation time is not required.
According to Taylor's theorem, C b (t) can be written as C b ͑t͒ = a 0 + a 1 t + a 2 t 2 + a 3 t 3 + иии .
[13]
Because all the H 2 17 O concentrations are expressed in excess of the natural abundance H 2 17 O concentration, C b is zero at the beginning of the inhalation; thus, a 0 ‫ס‬ 0. Similarly, CBFf 2 [C a (t) − C v (t)] can also be written as:
with the boundary condition that C v and C a are both zero at the beginning of the inhalation; i.e., C v (0) ‫ס‬ C a (0) ‫ס‬ 0. Using these expansions and the boundary conditions, Eq. 3 becomes: a 1 + 2a 2 t + 3a 3 t 2 + иии = 2␣f 1 CMRO 2 + a 1 Јt + a 2 Јt 2 + a 3 Јt 3 + иии .
[15]
Because Eq. 15 holds for any t value, applying the polynomial theorem to Eq. 15 at t ‫ס‬ 0 leads to:
Eq. 17 and all the previous derivations lay the mathematical foundation of method II. If the C b (t) curve is fitted by a polynomial in the form of Eq. 13 with a 0 ‫ס‬ 0, the coefficient of the first linear term (i.e., a 1 ) can be used to calculate CMRO 2 according to Eq. 17. Fitting a polynomial equation with infinite degree is obviously impossible for real data. In principle, the higher the order of the polynomial is used, the better the fit. However, this notion is only valid when all the data are noise-free. When noise is taken into account, larger variances in the fitted parameters will be potentially induced by fitting the data to the polynomials of larger degrees as the statistical power of fitting decreases; thus, the fitted results will be less reliable. Practically, only linear and quadratic terms were used for fitting our experimental data on C b (t) including the zero point of C b (t ‫ס‬ 0) ‫ס‬ 0 for each voxel to increase the fitting reliability.
Verification of the validity of the two models
The most straightforward way to verify the validity of the simplified methods is to compare the results obtained by using these simplified methods with the results from the complete model which requires determination of all parameters C a (t), CBF, and n, as well as other known constants such as m.
MATERIALS AND METHODS
The details of the experimental measurements used in this study are the same as those previously reported in a study we conducted to explore the feasibility of the 17 O MR approach for imaging CMRO 2 in a small-animal model during a brief inhalation of 17 O 2 gas at 9.4 T (Zhu et al., 2002) . We briefly describe these measurements here for convenience.
NMR measurements
All NMR experiments were performed on a 9.4-T, 31-cm bore magnet (Magnex Scientific, Abingdon, U.K.) interfaced to a Unity INOVA console (Varian, CA, U.S.A.). The spatial localization of 17 O MRS was achieved by using the threedimensional Fourier Series Window MRS imaging technique (Zhu et al., 2002) . The acquisition parameters for acquiring each three-dimensional 17 O-MRS image were as follows: repetition time for NMR data acquisition, 12 milliseconds; echo time, 0.4 milliseconds; total scan average, 948; spectral width, 30 kHz; 9 × 9 × 5 phase encodes; and 0.1 mL voxel size.
Animal preparation
Male Sprague-Dawley rats were anesthetized with approximately 2% (v/v) isoflurane in a mixture of O 2 and N 2 O gases (2:3) during surgery. After oral intubations, femoral artery and vein were catheterized for physiologic monitoring, blood sampling, and chemical administration. After surgery, anesthesia was switched to ␣-chloralose using continuous infusion of 0.4 mL/h of 15-mg/mL ␣-chloralose solution during the entire NMR measurement period (Zhu et al., 2002) . The rectal temperature of the rats was maintained at 37°± 1°C by using a heated water blanket.
CBF measurements
For CBF measurements, one external carotid artery was catheterized for gaining access to the internal carotid artery without interrupting blood circulation into brain (Zhu et al., 2001) . A small amount (0.05 to 0.1 mL) of 40%-to 50%-enriched H 2 17 O was rapidly injected into the brain via the internal carotid artery, and three-dimensional 17 O MRS imaging was used for monitoring the H 2 17 O washout processes and for determining CBF values (Zhu et al., 2001) . Fitting the signal decay curve of the H 2 17 O tracer in the brain with an exponential decay according to Eq. 12 gave the CBF value in each 17 O image voxel.
C a (t) measurements
An implanted vascular RF coil was designed and constructed for continuously detecting the 17 O MR signal changes of H 2 17 O in the rat carotid artery at 9.4 T. The coil was based on a modified solenoid coil design combined with an RF shielding (Zhang et al., 2003) . The entire coil had a compact physical size and was readily implanted into the rat body and wrapped around the rat carotid artery. The RF shielding ensured that the 17 O NMR signal detected by the implanted coil originated only from the artery blood (approximately 7 L blood volume) covered by the coil, without contaminations from surrounding tissues-therefore, additional spatial localization was not necessary for determining C a (t). In addition, the RF shielding minimized the electromagnetic coupling between the implanted 17 O coil and the head 17 O surface coil tuned at the same operating frequency (two-coil configuration), which allowed simultaneous measurements of both C a (t) and C b (t) with the same temporal resolution (11 seconds).
O 2 inhalation experiments
For 17 O 2 inhalation studies, the 17 O-labeled O 2 gas with 72% enrichment (Isotec Inc. OH, U.S.A.) was mixed with N 2 O gas (approximately 2:3 volume ratio) and then stored in a cylindrical gas reservoir. The three-dimensional 17 O MRS imaging acquisitions started with the normal gas mixture containing nonlabeled O 2 gas for 2 minutes; these natural abundance three-dimensional 17 O MRS images were used as references for the calibration of metabolic H 2 17 O concentrations in the rat brain during and after the 17 O 2 inhalation. Subsequently, the respiration gas was quickly switched to the 17 O 2 labeled gas mixture. After 2 minutes of 17 O 2 inhalation, the gas line was switched back to the normal gas mixture and the threedimensional 17 O MRS imaging acquisitions were continued throughout the measurement, and a total of 100 images were collected in approximately 19 minutes (Zhu et al., 2002) .
Determination of constant n
The ratio between the washout rate of the metabolic H 2 17 O after the cessation of 17 Figure 2A illustrates the simulation results showing the dependence of calculated CMRO 2 values on different values of the parameter A in the simplified model of method I (Eq. 10). In this simulation, the values of CMRO 2 ‫ס‬ 2.2 mol/g/min, A ‫ס‬ 2.0 mol/(g blood water)/min and CBF ‫ס‬ 0.6 (mL blood)/(g brain tissue)/min were assumed. As the A value increases, the CMRO 2 values calculated for different time points change from time-dependent with CMRO 2 increasing with time, to time-independent and again to timedependent with CMRO 2 now decreasing with time. Only the value of A ‫ס‬ 2.0 mol/(g blood water)/min provided a constant value of CMRO 2 ‫ס‬ 2.2 mol · g −1 · min −1 as expected.
RESULTS
CMRO 2 calculation results using simplified modeling (method I)
Simplified method I was applied to the experimental data obtained in the form of images of C b (t) and CBF measured from seven animals, which were previously published (Zhu et al., 2002) . Figure 2B demonstrates one example of simplified method I applied to data from a single voxel from a representative rat. In this calculation, the A value varied from 0 to 10 with the step size 0.05 (mol · (g blood water) −1 · min −1 ). As discussed in the Theory section, the correct A value should yield a time independent CMRO 2 for this steady state. The first two points (represented by open circles) in this experimental data were not included in this calculation because their signal-to-noise ratio is low due to insufficient H 2 17 O buildup and that a delay is expected after the onset of inhalation of the 17 O 2 labeled gas and before the 17 O 2 content in brain reaches a value that exceed the K m of cytochrome oxidase; only when the 17 O 2 concentration exceeds the K m of cytochrome oxidase for O 2 should the value calculated for CMRO 2 from the 17 O data become time independent. Linear least square fitting was used to fit the CMRO 2 values calculated according to Eq. 10 based on the experimental C b (t) data as a function of measurement time as well as the CBF and n values. The linear correlation coefficient (R) of the fitting was calculated ( Fig. 2B) . Among all the tried A values, the one under which CMRO 2 was the least correlated to the measurement time t (the smallest R square value) was considered to be the true value of A. The average of the calculated CMRO 2 values for all the time points (first two points excluded) under the true A value was used as the true CMRO 2 value. The final value of CMRO 2 using method I for the comparison later was averaged from seven animal measurements.
CMRO 2 calculation results using simplified modeling (method II)
Linear and quadratic polynomials were used to fit the observed C b (t) curves from individual image voxels as a function of time for CMRO 2 calculation using method II as described in Theory. The experimental data and the fits obtained using only a linear or quadratic dependence on time in a representative rat are shown in Figs. 3A and 3B (single voxel results). The averaged CMRO 2 values over all voxels in the brain for each individual animal (n ‫ס‬ 7) using method II (both linear and quadratic fitting results) are summarized in Fig. 4 . In comparison with the gray matter, the fraction of the white matter volume in the rat brain is much smaller than that of other animals (e.g., cats and nonhuman primates) and humans. Therefore, the averaged CMRO 2 values in Fig. 4 should approximately reflect the averaged oxygen utilization rates in the gray matter in the rat brain.
Validation of two simplified methods
As displayed in Fig. 4 , the average CMRO 2 values calculated with both the simplified methods were in good agreement with that calculated using the complete model for the 17 O MR-based CMRO 2 measurements from the same 17 O data (Zhu et al., 2002) . Paired t-tests were used to compare the CMRO 2 values calculated with different models, and only the linear fitting approach (method II) was found to be statistically significantly different from the complete model (P ‫ס‬ 0.03). However, the difference between the calculated CMRO 2 values using the complete model and the linear fitting approach was small (<10%).
FIG. 2. (A)
Simulated data illustrating the tendency of the calculated CMRO 2 values as A is varied. True CMRO 2 value is obtained when the CMRO 2 values calculated for all the timing points converge a constant. (B) CMRO 2 calculation using experimental data and method I. The A value is varied until CMRO 2 values calculated are the least correlated to the inhalation time. In this simulation, the true values of CMRO 2 = 2.2 µmol · g −1 · min −1 , A = 2.0 µmol · (g blood water) −1 · min −1 and CBF = 0.6 (mL blood) · (g brain tissue) −1 · min −1 are assumed.
DISCUSSION
Method I, in principle, should provide a more accurate CMRO 2 value as long as the assumptions made in this method hold. However, because the criterion for the evaluation of constant CMRO 2 based on the linear cor-relation coefficient is fairly sensitive to the noise fluctuations of the 17 O signal of cerebral H 2 17 O, variance of the CMRO 2 value from a single voxel calculated by method I is relatively large compared with method II. In contrast, method II, though it requires more approximations, is more tolerant to the noise variance and hence may be more reliable and robust than method I. In addition, the parameter of CBF is not necessary in method II. This can be also attributable to less variance in the fitting using method II.
Eq. 3 indicates that the right side in the equation composes two terms: a constant term 2␣f 1 CMRO 2 and a time variable term of CBFf 2 [C a (t) − C v (t)]. If C a (t) and C v (t) happen to cancel each other, then Eq. 3 can be readily solved with the solution of C b (t) ‫ס‬ 2␣f 1 CMRO 2 t. Under our experimental conditions, this condition is likely to be satisfied because of the observation of good approximation for the linear fitting of the experimental C b (t) curves. In general, however, this condition cannot be guaranteed under all circumstances. When C a (t) and C v (t) deviate from each other, the C b (t) curve as a function of t can deviate from a straight line. In this case, the use of quadratic or higher-order polynomial fitting should provide a better accuracy for CMRO 2 calculation.
The fact that the linear fitting approach in method II produces a good approximation for providing CMRO 2 values, which are close to the true CMRO 2 values determined by the complete model under our experimental conditions, implies that the difference between f 2 C a (t) and nC b (t)/ terms in Eq. 6, where C b (t) is usually larger than C a (t), is small and its influence on the CMRO 2 calculation is negligible. One crucial observation supporting this notion is the limited water permeability across the mitochondria membranes leading to a small FIG. 4. Comparison of calculated CMRO 2 results from seven measurements based on the simplified methods (method I; method II using the linear fitting or quadratic fitting approach) and the complete model. The last (right) column represents the averaged CMRO 2 value of seven animal measurements. All error bars represent the standard deviation errors.
FIG. 3. CMRO 2 calculation using the experimental data of one single voxel from a representative rat and (A) the linear fitting, or (B) the quadratic fitting approach, respectively, as proposed in method II. CMRO 2 was calculated according to Eq. 17. constant n (< 1) (Zhu et al., 2002) ; consequently, a small difference between the two terms. It is possible that this approximation may hold under other physiologic conditions; for example, under a stimulus specific activation in the brain when regional CBF is expected to increase significantly but the CMRO 2 increase is relatively less, so that the rate of metabolically produced H 2 17 O in the whole body will not be altered significantly. However, this possibility needs further validations in different species at different physiologic conditions. The success of these validations is important for potential human applications, where any elimination of invasive procedures is highly desirable if not absolutely necessary.
CONCLUSION
The results from this work validate the simplified modeling methods described in this article for calculating CMRO 2 . They suggest that the 17 O MR approach with the simplified modeling is capable of determining and imaging CMRO 2 even in the absence of the arterial input function or CBF measurements. The combination of the simplified modeling and ultrahigh-field 17 O NMR may potentially provide a robust, reliable, and completely noninvasive tool for studying the central role of oxidative metabolism in brain function and neurologic diseases in vivo.
